CSPC Pharmaceutical Group Limited
CHJTF
$1.28
$0.0756.25%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.75B | 4.03B | 4.20B | 4.38B | 4.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.75B | 4.03B | 4.20B | 4.38B | 4.52B |
| Cost of Revenue | 1.18B | 1.21B | 1.24B | 1.25B | 1.29B |
| Gross Profit | 2.56B | 2.82B | 2.97B | 3.13B | 3.23B |
| SG&A Expenses | 1.16B | 1.35B | 1.38B | 1.43B | 1.52B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.08B | 3.29B | 3.32B | 3.38B | 3.50B |
| Operating Income | 670.48M | 745.60M | 886.98M | 1.00B | 1.02B |
| Income Before Tax | 735.35M | 775.12M | 905.76M | 1.04B | 1.07B |
| Income Tax Expenses | 154.07M | 172.32M | 179.74M | 199.89M | 200.00M |
| Earnings from Continuing Operations | 581.28 | 602.80 | 726.02 | 840.17 | 870.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.43M | -1.49M | -10.22M | -19.29M | -24.60M |
| Net Income | 579.86M | 601.31M | 715.80M | 820.88M | 846.03M |
| EBIT | 670.48M | 745.60M | 886.98M | 1.00B | 1.02B |
| EBITDA | 815.53M | 885.34M | 1.02B | 1.13B | 1.14B |
| EPS Basic | 0.05 | 0.05 | 0.06 | 0.07 | 0.07 |
| Normalized Basic EPS | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 |
| EPS Diluted | 0.05 | 0.05 | 0.06 | 0.07 | 0.07 |
| Normalized Diluted EPS | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 |
| Average Basic Shares Outstanding | 46.55B | 46.95B | 47.24B | 47.38B | 47.42B |
| Average Diluted Shares Outstanding | 46.55B | 46.95B | 47.24B | 47.39B | 47.43B |
| Dividend Per Share | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
| Payout Ratio | -- | -- | -- | -- | -- |